吸入伊洛是一种有效的替代疗法,用于新生儿持续性肺高血压的治疗
1Istanbul Prof. Dr. Cemil Tascioglu City Hospital, Neonatal Intensive Care Unit University of Health Sciences Istanbul Sisli Turkey.
Pulmonary circulation
|July 20, 2023
概括
吸入性伊洛普罗斯特作为治疗新生儿持续性肺高血压 (PPHN) 的治疗方法具有前景. 这项研究发现,当吸入氧化 (iNO) 不存在时,它在新生儿中是有效和安全的.
科学领域:
- 新生儿医学 新生儿医学
- 儿童心脏病学 儿童心脏病学
- 呼吸系统医学 呼吸系统医学
背景情况:
- 新生儿持续性肺高血压 (PPHN) 是一种具有高发病率和高死亡率的关键新生儿疾病.
- 吸入氧化 (iNO) 是一种标准的治疗方法,但需要替代方法.
- 吸入性伊洛普罗斯特 (prostacyclin) 是一种潜在的替代品,但对其在新生儿中使用的数据有限.
研究的目的:
- 评估吸入伊洛普罗斯特作为新生儿PPHN的救援疗法的有效性和安全性.
- 为了确定这个人群中吸入伊洛普罗斯特的最佳剂量和施用参数.
主要方法:
- 对六名被诊断患有PPHN的新生儿进行了回顾性研究,这些新生儿接受了吸入性伊洛普罗斯特治疗.
- 收集的数据包括人口和临床特征,剂量,氧化指数变化,心声回声检测结果和死亡率.
- 吸入性伊洛普罗斯特剂量:2-4毫克克/剂量,3-48次/天吸入2-7天.
主要成果:
- 吸入的伊洛普罗斯特在所有6名患者中都有效.
- 没有观察到任何不良副作用.
- 在研究队列中没有记录死亡率.
结论:
- 吸入性伊洛普罗斯特可以被认为是新生儿PPHN的可行的第一线治疗方法,特别是当iNO无法获得时.
- 需要进一步的研究来优化剂量和管理,解决氧化指数的波动.
- 安全性概况表明,吸入的伊洛普罗斯特是PPHN的耐受性良好的治疗选择.
相关概念视频
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
216
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
216
Treatment for Pulmonary Arterial Hypertension: Oxygen Therapy for Respiratory Failure
266
Oxygen therapy has emerged as a significant tool in enhancing the quality of life for patients suffering from pulmonary arterial hypertension (PAH). While this therapy has principally been studied on patients with significant hypoxemia, this therapeutic approach helps prevent potential organ damage and can be administered in the comfort of one's home.
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
Oxygen therapy is vital in increasing and maintaining blood oxygen levels in PAH patients. As a result, it aids in reducing fatigue,...
266
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
202
Endothelins (ETs) are potent vasoactive peptides critical in the human body's various physiological and pathological processes. One of the most promising therapeutic strategies for treating pulmonary arterial hypertension (PAH) involves counteracting the effects of these endothelins using a class of drugs known as endothelin receptor antagonists.
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
202
Mechanical Ventilation III: Noninvasive Ventilation
152
Noninvasive positive-pressure ventilation (NIPPV), continuous positive airway pressure (CPAP), and bilevel positive airway pressure (BiPAP) are essential methods in respiratory care. These ventilation techniques offer unique benefits for patients with various respiratory conditions, providing adequate support without requiring intubation. Let's explore how each method is crucial in improving patient outcomes and enhancing respiratory therapy.
Noninvasive Positive-Pressure Ventilation...
Noninvasive Positive-Pressure Ventilation...
152
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
10
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
10
COPD: Management Using Bronchodilators and Corticosteroids
249
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
249


